Startups
QuTEM delivers TEM analysis of AAV, lentivirus, LNP, phage, MVA and more — from R&D to commercial release. Labs in Stockholm and Boston.
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 20, 2026 | CryoTEM breaks ground as new method added to U.S. Pharmacopeia's updated AAV reference standard certificates | AAV full/empty/intermediate CryoTEM Micrograph and Population Distribution USP recognizes CryoTEM for characterizing empty/full/intermediate capsids on AAV8 reference standards STOCKHOLM, STOCKHOLM, SWEDEN, May 20, 2026 /EINPresswire.com/ -... |
| Mar 10, 2026 | QuTEM Collaborates with Boston University to Bring Advanced Quality Control Analysis to American Gene Therapy Developers | QuTEM and Boston University collaborate to provide localized, high-speed AAV analysis for North American gene therapy developers. STOCKHOLM, STOCKHOLM, SWEDEN, March 10, 2026 /EINPresswire.com/ -- QuTEM AB, a world-leading provider of GMP-c... |
| May 17, 2024 | QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency | STOCKHOLM, Sweden, May 17, 2024 (GLOBE NEWSWIRE) -- QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Cert... |
| May 17, 2024 | Certification BPF pour QuTEM, et délivrance d’un permis de fabrication par l’agence suédoise des produits médicaux pour son laboratoire de microscopie électronique en transmission | STOCKHOLM, Suède, 18 mai 2024 (GLOBE NEWSWIRE) -- QuTEM AB, anciennement Vironova BioAnalytics AB, un fournisseur de services de microscopie électronique en transmission (ou « MET ») de première importance, est fier d´annoncer l’obtention d... |
| May 17, 2024 | QuTEM erhält GMP-Zertifikate und Herstellungserlaubnis für das Labor für Transmissionselektronenmikroskopie von der schwedischen Behörde für Medizinprodukte | STOCKHOLM, Schweden, May 18, 2024 (GLOBE NEWSWIRE) -- QuTEM AB (ehemals Vironova BioAnalytics AB), ein führender Anbieter von Dienstleistungen im Bereich der Transmissionselektronenmikroskopie (TEM), gibt mit Stolz den Erhalt von GMP-Zertif... |
| Nov 22, 2023 | Venture Targeter joins leading European venture investors in inaugural special situation investment | Venture Targeter joins leading European venture investors in inaugural special situation investment Wed, Nov 22, 2023 09:11 CET Report this content Venture Targeter AB ("Venture Targeter"), a strategic investment company founded b... |
Reviews 0
FAQ about QuTEM
What has the press written about QuTEM?
Parsers VC has collected 7 articles mentioning QuTEM, among them “CryoTEM breaks ground as new method added to U.S. Pharmacopeia's updated AAV reference standard certificates” (May 20, 2026) and “QuTEM Collaborates with Boston University to Bring Advanced Quality Control Analysis to American Gene Therapy Developers” (Mar 10, 2026).
Is QuTEM still active?
Yes, QuTEM is active; its latest activity on Parsers VC dates from Aug 18, 2026.